Prognostic Value of Progranulin in Patients with Colorectal Cancer Treated with Curative Resection
- Authors
- Koo, Dong-Hoe; Do, In-Gu; Oh, Suk Joong; Lee, Yun-Gyoo; Kim, Kyungeun; Sohn, Jin Hee; Park, Soo-Kyung; Yang, Hyo-Joon; Jung, Yoon Suk; Park, Dong Il; Jeong, Kyung Uk; Kim, Hyung Ook; Kim, Hungdai; Serrero, Ginette; Chun, Ho-Kyung
- Issue Date
- Oct-2018
- Publisher
- SPRINGER
- Keywords
- Progranulin; Colorectal neoplasms; Recurrence; Prognosis
- Citation
- PATHOLOGY & ONCOLOGY RESEARCH, v.26, no.1, pp.397 - 404
- Indexed
- SCIE
SCOPUS
- Journal Title
- PATHOLOGY & ONCOLOGY RESEARCH
- Volume
- 26
- Number
- 1
- Start Page
- 397
- End Page
- 404
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/191503
- DOI
- 10.1007/s12253-018-0520-7
- ISSN
- 1219-4956
- Abstract
- Progranulin (PGRN) has been characterized as an autocrine growth and survival factor and is known to stimulate tumorigenesis and proliferation of several types of cancer cell. However, little is known about the prognostic role of PGRN in colorectal cancer (CRC). A retrospective analysis was performed for patients with colorectal cancer who underwent curative resection between May 2013 and June 2015. PGRN expression in tumor cells was semi-quantitatively categorized (no expression, 0; weak/focal, 1+; moderate/focal or diffuse, 2+; strong/diffuse, 3+), and high expression was considered for tumors graded >= 2+ staining intensity. A total of 109 patients (28 stage I, 32 stage II, and 49 stage III) were analyzed. Thirty-eight patients (35%) had tumors with high PGRN expression, and there was a trend of elevated pre-operative CEA and CA19-9 levels in patients with high PGRN-expressing tumors compared to those with low PGRN-expressing tumors (CEA, 49% vs. 21%; CA19-9, 21% vs. 7%). The 3-year recurrence-free survival (3Y-RFS) and overall survival rates were 83.7% (95% CI, 76.8-90.6) and 96.0% (95% CI, 92.3-99.7), respectively. Patients with high PGRN-expressing tumors had a worse rate of 3Y-RFS (66.8%) compared to those with low PGRN-expressing tumors (92.4%; p = 0.010). Multivariate analysis showed that high PGRN expression, age (>66 years), stage (III), and perineural invasion (+) were independent prognostic factors associated with poor RFS after adjusting for confounding factors including sex, MSI, tumor location, KRAS, and lympho-vascular invasion. PGRN overexpression was significantly associated with poor RFS in patients with CRC who have undergone curative resection.
- Files in This Item
-
Go to Link
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/191503)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.